Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Publication year range
1.
Int J Clin Pharm ; 41(3): 734-740, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30972535

ABSTRACT

Background Potentially inappropriate medication (PIM) and potential prescription omission (PPO) are common issues in pharmacotherapy in vulnerable populations. A first tool to assess PIM's and PPO's targeting pediatric populations: POPI «Pediatrics Omission of Prescriptions and Inappropriate Prescriptions¼ was created in 2014. Objective This study aimed to evaluate inter-rater reliability between healthcare professionals who apply POPI. Setting: Mother and child emergency ward of a university hospital. Method Twenty cases with or without PIM or PPO were identified in a previous retrospective PIM-PPO prevalence study on 15,973 patients. One doctor and one pharmacist, who participated in the creation of POPI tool, identified PIM and PPO ("gold standard response"). These cases were reviewed independently by eleven clinicians (generalists, pediatricians, pharmacists, residents), with no previous experience of this tool. Interrater agreement was calculated by using the Kappa agreement test. Main outcome measure: Inter-clinician agreement. Results A high level of agreement of PIM and PPO detection was recorded (PIM: median = 0.80; PPO: median = 0.71). Conclusion POPI demonstrated a good interrater reliability. This validation by many clinicians proves that POPI is a reliable tool. Other multicenter and prospective studies should be conducted to evaluate economical and clinical impacts of POPI.


Subject(s)
Drug Prescriptions/standards , Inappropriate Prescribing/prevention & control , Medical Errors/prevention & control , Potentially Inappropriate Medication List/standards , Child , Child, Preschool , Cohort Studies , Female , Humans , Infant , Male , Reproducibility of Results , Retrospective Studies
2.
Arch Pediatr ; 23(5): 481-90, 2016 May.
Article in French | MEDLINE | ID: mdl-27067037

ABSTRACT

OBJECTIVE: Medication errors including inappropriate prescriptions and drug omissions are one of the causes of adverse drug events in children. Our aim was to develop a preliminary screening tool to detect omissions and inappropriate prescriptions in pediatrics based on French and international guidelines. MATERIEL AND METHODS: Disease classification was based on the prevalence rate of pathology and hospital statistics. The criteria were obtained by reviewing many French and international references. The Delphi consensus technique was used to establish the content validity of POPI. The level of agreement and the proposals of healthcare professionals was noted on a nine-point Likert scale. RESULTS: The criteria were categorized according to the main physiological systems (gastroenterology, respiratory infections, pain, neurology, dermatology, and miscellaneous). They were distributed to 16 French pediatric panelists (eight pharmacists, eight pediatricians who were hospital-based [50%] or working in the community [50%]). After two rounds of the Delphi process, 101 of 108 criteria were chosen with strong consensus (76 inappropriate prescriptions and 25 omissions). CONCLUSIONS: POPI is the first screening tool to detect inappropriate prescriptions and omissions in pediatrics. It is now necessary to conduct a prospective study to determine inter-rater reliability and the tool's detection capacity.


Subject(s)
Consensus , Drug Prescriptions/statistics & numerical data , Inappropriate Prescribing/statistics & numerical data , Pediatrics , Practice Patterns, Physicians'/statistics & numerical data , Adult , Aged , Female , France/epidemiology , Guidelines as Topic , Humans , Male , Middle Aged , Pharmacists/statistics & numerical data , Physicians/statistics & numerical data , Prevalence , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL